11. Legal Settlements Without Accountability
When faced with lawsuits, many pharmaceutical companies opted for financial settlements rather than admitting any wrongdoing. These payouts, while substantial, often represented only a fraction of their profits and rarely included meaningful penalties for executives or systemic change. As reported by NPR, these settlements allowed firms to avoid public accountability while continuing business operations with minimal disruption.
